# Added Value of Preoperative Contrast Enhanced Mammography in Staging of Malignant Breast Lesions

> **NCT04437602** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Region Halland** · enrollment: 441 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Contrast Enhanced Mammography (CEM)

## Key facts

- **NCT ID:** NCT04437602
- **Lead sponsor:** Region Halland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-11-02
- **Primary completion:** 2024-04-30
- **Final completion:** 2029-12-31
- **Target enrollment:** 441 (ACTUAL)
- **Last updated:** 2024-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04437602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04437602, "Added Value of Preoperative Contrast Enhanced Mammography in Staging of Malignant Breast Lesions". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04437602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*